Chemokine Therapeutics Corp CTI Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and immune system recovery. The company focuses on identifying chemokines and their associated receptors ...

Industries: Biological Therapy | Countries: Canada, United Kingdom

The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • by BCC Research
  • July 2014
  • 169 pages

This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2018. Use this report ...

Industries: Biological Therapy | Countries: World, United States, Europe, India, Canada, Germany, Japan, China, Brazil, Spain, Italy, France, Asia, Mexico, North America, United Kingdom

Chemokine Therapeutics Corp. (CTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chemokine Therapeutics Corp. (CTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 16 pages

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and immune system recovery. The company focuses on identifying chemokines and their associated receptors ...

Industries: Biological Therapy | Countries: Canada, United Kingdom

Global Circulating Tumor Cells and Cancer Stem Cells Technologies Industry

Global Circulating Tumor Cells and Cancer Stem Cells Technologies Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • March 2014
  • 213 pages

This report analyzes the worldwide markets for Circulating Tumor Cells and Cancer Stem Cells Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period ...

Industries: Biological Therapy | Countries: World, United States, Europe, Canada, Japan, France, Germany, Italy, Spain, North America, United Kingdom, Russian Federation

Biocompatibles International Ltd. - Strategic SWOT Analysis Review

Biocompatibles International Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • July 2013
  • 15 pages

Summary Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used for the treatment of cancer and benign tumors. The company is divided into two divisions, namely, oncology product division and a licensing division. The oncology division ...

Industries: Biological Therapy | Countries: United States, United Kingdom

Analysis of the Stem Cell Markets-Unlocking the New Era in Therapeutics 

Analysis of the Stem Cell Markets-Unlocking the New Era in Therapeutics 

  • $ 6 000
  • Industry report
  • by Frost & Sullivan
  • January 2012
  • 124 pages

This research service analyses the emerging stem cell therapeutics applications by geographic regions, encompassing Europe - The United Kingdom, Germany, Sweden, Belgium, Finland, France and Spain. The study covers various areas of interest such as regulatory policies within stem cell research, emerging ...

Industries: Biological Therapy | Countries: Europe, United Kingdom, Sweden, Spain, France, Germany, Finland, Belgium

Delving into Stem Cell Research and its Potential

Delving into Stem Cell Research and its Potential

  • $ 350
  • Industry report
  • by Aruvian's R'search
  • January 2012

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. As stem cells can be readily grown and transformed into specialized cells with characteristics ...

Industries: Biological Therapy | Countries: World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

  • $ 3 500
  • Industry report
  • by GBI Research
  • December 2011

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy ...

Industries: Biological Therapy | Countries: World, Australia, Brazil, Canada, Spain, Italy, Germany, Japan, India, China, France, United States, United Kingdom, Europe, Oceania, Asia, South America, North America

Global Lou Gehrig's Disease industry

Global Lou Gehrig's Disease industry

  • $ 3 450
  • Industry report
  • by Global Industry Analysts
  • April 2010

This report analyzes the Global market for Lou Gehrig's Disease in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 37 companies including many key and niche players such as Aeolus Pharmaceuticals, Inc., Amorfix Life Sciences Ltd., Avicena ...

Industries: Biological Therapy | Countries: World, United States, Canada, Australia, United Kingdom, France, Germany, Europe, North America, New Zealand, Oceania, Sweden, Taiwan, Israel

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.